Orbbec (SH:688322)2024-04-16 08:50Revenue Expectations - The company expects to achieve approximately CNY 93 million in revenue for Q1 2024, representing an increase of CNY 31.74 million or a year-over-year growth of 51.81%[3]. - In Q1 2023, the company's revenue was CNY 61.26 million, with a net loss attributable to shareholders of CNY 68.12 million[4]. Net Loss Projections - The company anticipates a net loss of approximately CNY 28 million for Q1 2024, reducing the loss by CNY 40.12 million or a decrease of 58.90% year-over-year[8]. - The expected net loss attributable to shareholders after deducting non-recurring gains and losses for Q1 2024 is approximately CNY 40 million, a reduction of CNY 43.60 million or 52.15% compared to the previous year[11]. Business Growth Drivers - The company has seen rapid growth in sectors such as medical insurance verification and 3D scanning, contributing to overall business growth[5]. - The company emphasizes the importance of self-developed core technologies and products in driving business breakthroughs[5]. Cost Management - The company has implemented cost control and efficiency measures, resulting in a significant decrease in operating expenses compared to the previous year[5]. Financial Reporting and Assurance - The financial data provided is preliminary and has not been audited by registered accountants, with final figures to be disclosed in the official Q1 2024 report[9]. - The company has not identified any significant uncertainties that could affect the accuracy of the performance forecast[13]. - The board of directors assures the accuracy and completeness of the announcement, taking legal responsibility for its content[2].